See also this year's filing and all EDGAR filings for this company.
PDF Report 0001173281_2021_NeuBase_Therapeutics_Inc.pdf
Logs
| warning | Missing logo | subcommand.report | {} |
| warning | Large missing amount for aggregate "Liabilities" added to remainder. | industry.us_generic | {'missing_ratio': inf, 'aggregate_val': 3149633, 'exp_sum': 0, 'exp_to_value': {'LiabilitiesCurrent': 0, 'LiabilitiesNoncurrent': 0, 'remainder_Liabilities': 0}} |
| info | Failed to set obs_EconomicCapitalRatio | industry.us_generic | {'reason': "KeyError('0001173281')"} |
Graph
Absolute values for 0001173281, NeuBase Therapeutics Inc.
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 32,808,540 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 1,166,934 |
| 3 | remainder_Assets | 468,807 |
| 4 | LiabilitiesCurrent | 0 |
| 5 | LiabilitiesNoncurrent | 0 |
| 6 | remainder_Liabilities | 3,149,633 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 10,123,298 |
| 9 | ResearchAndDevelopmentExpense | 6,946,008 |
| 10 | remainder_Expenses | 0 |
| 11 | remainder_Revenues | 0 |
| 12 | remainder_NetIncome | -315,214 |
| 13 | remainder_ComprehensiveNetIncome | 0 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 34,444,281 |
| 1 | Liabilities | 3,149,633 |
| 2 | Expenses | 17,069,306 |
| 3 | Revenues | 0 |
| 4 | StockholdersEquity | 31,294,648 |
| 5 | NetIncome | -17,384,520 |
| 6 | ComprehensiveNetIncome | -17,384,520 |
| 7 | BaseVar | 27,489,217 |
| 8 | EconomicCapitalRatio | 1.94 |
Edgar->Model Mapping
Feature Distribution
Change over Time
